Literature DB >> 10215831

Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group.

B P Wijnhoven1, P D Siersema, W C Hop, H van Dekken, H W Tilanus.   

Abstract

BACKGROUND: Adenocarcinomas of the distal third of the oesophagus and the gastric cardia have similar characteristics but different staging criteria are being used. In the present study the question is addressed whether these tumours should be regarded and staged as one clinical entity.
METHODS: From January 1987 to January 1997, 252 patients with an adenocarcinoma of the oesophagus (n = 111) or gastric cardia (n = 141) underwent transhiatal resection. Pathology, pathological tumour node metastasis (pTNM) stage and survival were analysed retrospectively, and a comparison was made between tumours of the oesophagus and gastric cardia.
RESULTS: Barrett's epithelium was diagnosed in 54 per cent of oesophageal adenocarcinomas compared with 13 per cent of adenocarcinomas of the gastric cardia (P < 0. 001). Oesophageal carcinomas had a more favourable pT stage, fewer positive locoregional lymph nodes (pN1-2 56 versus 62 per cent; P = 0.3), but more distant metastases accounted for by positive lymph nodes around the coeliac axis (pM1 19 versus 4 per cent; P < 0.001). Five-year overall survival (26 versus 27 per cent; P = 0.9) and survival according to tumour stage were no different between the groups. Multivariate analysis showed that the location of the primary tumour was not an independent prognostic factor.
CONCLUSION: Adenocarcinomas of the distal oesophagus and gastric cardia should be regarded as one clinical entity. Uniform staging criteria for both malignancies are recommended.

Entities:  

Mesh:

Year:  1999        PMID: 10215831     DOI: 10.1046/j.1365-2168.1999.01082.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  35 in total

Review 1.  Should we continue oesophageal surgery in a district general hospital? A review of 200 consecutive cases.

Authors:  G H Dickson; R Waters; J Bull; V Kaul; J Sitzia
Journal:  Ann R Coll Surg Engl       Date:  2001-05       Impact factor: 1.891

2.  Endoscopic ablation of Barrett's esophagus using high power setting argon plasma coagulation: a prospective study.

Authors:  Corrado Pedrazzani; Filippo Catalano; Mara Festini; Germana Zerman; Anna Tomezzoli; Andrea Ruzzenente; Alfredo Guglielmi; Giovanni de Manzoni
Journal:  World J Gastroenterol       Date:  2005-03-28       Impact factor: 5.742

3.  Systematic review with meta-analysis: prevalence of prior and concurrent Barrett's oesophagus in oesophageal adenocarcinoma patients.

Authors:  Mimi C Tan; Nabil Mansour; Donna L White; Amy Sisson; Hashem B El-Serag; Aaron P Thrift
Journal:  Aliment Pharmacol Ther       Date:  2020-05-26       Impact factor: 8.171

4.  Molecular cytogenetic evaluation of gastric cardia adenocarcinoma and precursor lesions.

Authors:  H van Dekken; J C Alers; P H Riegman; C Rosenberg; H W Tilanus; K Vissers
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

5.  Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients.

Authors:  J Rüdiger Siewert; M Feith; M Werner; H J Stein
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

Review 6.  Carcinoma of the gastroesophageal junction in Chinese patients.

Authors:  Qin Huang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

7.  Effect of body mass index on adenocarcinoma of gastric cardia.

Authors:  Ji Zhang; Xiang-Qian Su; Xiao-Jiang Wu; Ya-Hang Liu; Hua Wang; Xiang-Nong Zong; Yi Wang; Jia-Fu Ji
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

8.  Fluorodeoxyglucose-positron emission tomography in adenocarcinomas of the distal esophagus and cardia.

Authors:  Katja Ott; Wolfgang A Weber; Ulrich Fink; Hermann Helmberger; Karen Becker; Hubert J Stein; James Müller; Markus Schwaiger; Jörg Rüdiger Siewert
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

9.  Transthoracic versus abdominal-transhiatal resection for treating Siewert type II/III adenocarcinoma of the esophagogastric junction: a meta-analysis.

Authors:  Zhi Zheng; Jun Cai; Jie Yin; Jun Zhang; Zhong-Tao Zhang; Kang-Li Wang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

10.  Comparison of cyclooxygenase 2 expression in adenocarcinomas of the gastric cardia and distal oesophagus.

Authors:  C J Buskens; A Sivula; B P van Rees; C Haglund; G J A Offerhaus; J J B van Lanschot; A Ristimäki
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.